Clinical Trials Logo

Diabetic Neuropathy, Painful clinical trials

View clinical trials related to Diabetic Neuropathy, Painful.

Filter by:

NCT ID: NCT00501202 Completed - Clinical trials for Diabetic Polyneuropathy

Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN).

Start date: March 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety, effectiveness, and tolerability of 200 mg of RWJ-333369 given twice daily by mouth compared with placebo in the treatment of Diabetic Peripheral Neuropathy (DPN).

NCT ID: NCT00385671 Completed - Clinical trials for Diabetic Neuropathy, Painful

An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain

Start date: September 2006
Phase: Phase 4
Study type: Interventional

To test the non-inferiority of duloxetine monotherapy as a treatment for the management of diabetic peripheral neuropathic pain as compared to pregabalin treatment among patients who have not had an adequate response to gabapentin.

NCT ID: NCT00381719 Completed - Clinical trials for Diabetic Neuropathy, Painful

Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy

Start date: October 2006
Phase: Phase 2
Study type: Interventional

This study will explore the safety and effectiveness of different doses of AGN 203818 in treating pain in patients with painful diabetic peripheral neuropathy

NCT ID: NCT00266643 Completed - Clinical trials for Diabetic Neuropathy, Painful

Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve Pain

Start date: December 2005
Phase: Phase 4
Study type: Interventional

This study is to compare the tolerability of different methods for switching from another medication to duloxetine for the management of diabetic nerve pain. The primary objective is to compare the most gradual method with the most abrupt method, to see if they have different tolerability.

NCT ID: NCT00159679 Completed - Clinical trials for Diabetic Neuropathy, Painful

Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy

Start date: September 2004
Phase: Phase 4
Study type: Interventional

The purposes of this study are to: 1) find out if pregabalin relieves pain in subjects with painful diabetic peripheral neuropathy; 2) find out if pregabalin is safe at a dose of 600 mg/day (taken twice a day); and 3) find out if changes in nerve function happen during the study.

NCT ID: NCT00156078 Completed - Clinical trials for Diabetic Neuropathy, Painful

A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN)

Start date: January 2005
Phase: Phase 4
Study type: Interventional

A study of pregabalin efficacy and safety in a racially and culturally diverse group of subjects with painful diabetic peripheral neuropathy (DPN).

NCT ID: NCT00150423 Completed - Clinical trials for Diabetic Neuropathy, Painful

To Evaluate the Safety and Efficacy of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.

Start date: January 2001
Phase: Phase 3
Study type: Interventional

To evaluate the safety and efficacy of pregabalin in patients with painful diabetic peripheral neuropathy.

NCT ID: NCT00141401 Completed - Clinical trials for Diabetic Neuropathy, Painful

Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.

Start date: September 1999
Phase: Phase 3
Study type: Interventional

To evaluate long-term efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy.

NCT ID: NCT00073034 Terminated - Diabetes Mellitus Clinical Trials

Study Evaluating EAA-090 in Adult Outpatients With Neuropathic Pain Associated With Diabetic Neuropathy

Start date: January 2004
Phase: Phase 2
Study type: Interventional

EAA-090 is being developed for the treatment of neuropathic pain associated with diabetic neuropathy. It is a selective antagonist that binds competitively to the glutamate site of the N-methyl-D-aspartate (NMDA) receptor. This study will assess the safety and efficacy of 3 fixed oral doses of EAA-090 compared with placebo in subjects with neuropathic pain associated with diabetic neuropathy.

NCT ID: NCT00058968 Completed - Clinical trials for Diabetic Neuropathy, Painful

A Study for the Treatment of Painful Diabetic Neuropathy

Start date: October 2002
Phase: Phase 3
Study type: Interventional

The purpose of the study is to determine if duloxetine can help patients with painful diabetic neuropathy.